Table 3.
Advantages | Limitations | |
---|---|---|
Micro-particles | Subcutaneous injections Intramuscular injections Controlled release Reproducible processes |
Unintended toxic side effect due to high initial burst Wasteful use of expensive drugs due to initial burst release |
| ||
Nano-particles | Direct injection to the blood Potentially improved vaccine responses |
Non-specific uptake by reticuloendothelial system (RES) systems Potential immunotoxicity |